Clinical analysis for the development of extensively drug-resistant tuberculosis in Chongqing,China

Xiyan ZHANG,Jialin JIN,Xiaoping FAN,Ying RAO,Min ZHONG,Ying ZHANG,Wenhong ZHANG

2011-01-01

Abstract:Objective Epidemics of drug-resistant tuberculosis may emerge by two mechanisms: acquired resistance and primary resistance. It is very important to distinguish between these two mechanisms of clinical failure, because control of the former depends on better management of patients, whereas controlling the latter requires enhanced efforts to find and treat infectious cases to interrupt transmission. Methods We collected 90 XDR-TB cases with complete history and analyzed the reasons of clinical failure. Results We found that primary resistance was most frequent, accounted for 52.2% of XDR-TB, which was defined as resistant-culture result before treatment or no improvement after 3 month standard treatment. About 33.3% of XDR-TB was associated with irregular treatment, of which poor patient adherence accounted for 66.7% (20/30). Interrupted therapy owing to adverse drug reaction including damaged liver function, gastrointestinal adverse reaction, rash, optic neuritis accounted for 23.3% of all XDR-TB cases. Inadequate initial treatment regimen was associated with 8.9% of the XDR-TB cases. XDR-TB was isolated from local lesions (intra-spinal abscess, intra-ab-dominal abscess and pleural effusion) in 3 cases. Another one case developed from mono-resistant before treatment to XDR later during therapy. Conclusions Although definite history of close contact is not so prevalent (11.1%), more than half of cases had primary resistance suggesting the transmission of drug-resistance, which will need more education and isolation to prevent further transmission within the community. Irregular treatment and inadequate initial treatment regimen remain an important factor leading to resistance. DOTS program should be strengthened.